ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

KYTX vs ALEC // 10Y YIELD & FRED MACRO BETA

Kyverna Therapeutics Inc. (NASDAQ) VS. Alector Inc. (NASDAQ) • 15-METRIC TALLY: KYTX 2 — ALEC 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KYTX VS. ALEC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC KYTX ALEC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -65.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 KYTX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 41.8 59.7 -17.90 ALEC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $350.7M $327.6M $23.0M KYTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR KYTX REV ALEC REV KYTX GROSS % ALEC GROSS % KYTX FCF ALEC FCF
FY 2025 $475.5M $21.0M — — -$153.7M -$184.1M
FY 2024 $399.3M $100.6M — — -$116.5M -$231.2M
FY 2023 $174.7M $97.1M — — -$52.4M -$184.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KYTX // BETA —
ALEC // BETA —